Here is a breakdown of six recalls reported by Becker’s Hospital Review or published by the FDA in the last two weeks.
1. Recalled drug: Montelukast sodium tablets
Reason for recall: Bottles contained the wrong drug. The sealed bottles were supposed to contain 30 Montelukast sodium tablets, but instead contained 90 Losartan potassium tablets.
Date of recall: Aug. 31
Drugmaker: Camber Pharmaceuticals
2. Recalled device: CyPass Micro-Stent
Reason for recall: A long-term safety study revealed that patients with the stent experienced statistically significant endothelial cell loss, compared to the group that underwent cataract surgery alone.
Date of recall: Aug. 29
Devicemaker: Alcon, a subsidiary of Novartis
3. Recalled drugs: All nasal products and baby oral gels
Reason for recall: Expanded recall due to possible microbial contamination at the drugmaker’s Florida plant.
Date of expanded recall: Aug. 28
Drugmaker: Product Quest Manufacturing
4. Recalled drug: Hydrochlorothiazide tablets
Reason for recall: Labeling mix-up. The affected product was supposed to contain hydrochlorothiazide tablets, but instead contained spironolactone tablets.
Date of recall: Aug. 27
Drugmaker: Accord Healthcare
5. Recalled drug: Children’s Advil suspension-bubble gum flavored
Reason for recall: Dosage labeling error. The dosage cup provided in the package is marked with teaspoons, while the instructions on the label describe dosage information in milliliters.
Date of recall: Aug. 27
Drugmaker: Pfizer Consumer Healthcare, the pharma giant’s over-the-counter division
6. Recalled drugs: 32 children’s medications, ranging from cough relief, sleep aids and stress relief
Reason for recall: Microbial contamination
Date of recall: Aug. 22
Drugmaker: King Bio
More articles on pharmacy:
Hospitals mark up drugs by 479%: 6 report findings
Narcan maker to be acquired by Emergent Biosolutions for $735M
US-Mexico trade deal grants drugmakers 10 years of patent exclusivity on biologics
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.